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http://dx.doi.org/10.1016/j.stemcr.2017.09.005SUMMARYRat embryonic stem cells (ESCs) offer the potential for sophisticated genome engineering in this valuable biomedicalmodel species. How-
ever, germline transmission has been rare following conventional homologous recombination and clonal selection. Here, we used the
CRISPR/Cas9 system to target genomicmutations and insertions.We first evaluated utility for directedmutagenesis and recovered clones
with biallelic deletions in Lef1. Mutant cells exhibited reduced sensitivity to glycogen synthase kinase 3 inhibition during self-renewal.
We then generated a non-disruptive knockin of dsRed at the Sox10 locus. Two clones produced germline chimeras. Comparative expres-
sion of dsRed and SOX10 validated the fidelity of the reporter. To illustrate utility, live imaging of dsRed in neonatal brain slices was em-
ployed to visualize oligodendrocyte lineage cells for patch-clamp recording. Overall, these results show that CRISPR/Cas9 gene editing
technology in germline-competent rat ESCs is enabling for in vitro studies and for generating genetically modified rats.INTRODUCTION
The rat Rattus is a valuable andwidely usedmodel organism
for studying cognition and behavior, physiology, toxi-
cology, and various pathologies, such as metabolic and
neurodegenerative diseases (Iannaccone and Jacob, 2009).
Although the rat was the first mammalian species to be
domesticated for biomedical research (Jacob et al., 2010),
it has been outpaced in recent years by the mouse, in part
because of limitations in directed manipulation of the rat
genome. Inmice, genome engineering is mostly performed
via embryonic stem cells (ESCs), and the ease of carrying
out such work has been key to their widespread use as an
animal model (Capecchi, 2005). Following the definition
of culture requirements for mouse ESCs (Ying et al.,
2008), rat ESCs have been derived from different rat strains
using similar conditions (Buehr et al., 2008; Hirabayashi
et al., 2010a; Li et al., 2008). However, rat ESCs are less
robust than their mouse counterparts and demand expert
handling tomaintain robust growth and capacity for germ-
line transmission (Blair et al., 2011), especially after clonal
selection required for gene targeting (Hirabayashi et al.,
2010b, 2013, 2014; Meek et al., 2010; Men et al., 2012;
Men and Bryda, 2013; Tong et al., 2010). These technical
difficulties have hindered the widespread adoption of rat
ESC transgenesis.
Meanwhile, the development of the CRISPR/Cas9 sys-
tem (Cho et al., 2013; Cong et al., 2013; Hwang et al.,
2013; Ma et al., 2014; Mali et al., 2013; Shen et al., 2013;
Wang et al., 2013; Yang et al., 2013) has enabled rat
genome editing via direct injection of one-cell embryos
(Kim and Kim, 2014; Li et al., 2013a, 2013b; Ma et al.,1262 Stem Cell Reports j Vol. 9 j 1262–1274 j October 10, 2017 j ª 2017 Th
This is an open access article under the CC BY license (http://creativecommo2014; Shao et al., 2014). The injected endonuclease is tar-
geted to a specific DNA sequence by guide RNAs (gRNAs)
and introduces double-strand breaks, which can be re-
paired by non-homologous end-joining (NHEJ) (Garneau
et al., 2010; Lieber, 2010; Marraffini and Sontheimer,
2010). Error-prone NHEJ generally introduces small indels
at the cleavage site to generate mutation in one or both al-
leles of the target sequence. Several knockout rats have
been generated using this method (Li et al., 2013a,
2013b). More recently, insertion of large DNA fragments
at target loci has been achieved using single-stranded oligo-
deoxynucleotides (ssODNs) together with CRISPR/Cas9
(Chen et al., 2011; Storici et al., 2006; Yoshimi et al.,
2014, 2016). However, targeting efficiency varies unpre-
dictably between different loci and according to the size
of the insert. Moreover, both methods are inefficient and
require injections of large numbers of embryos with
associated maintenance of substantial numbers of
animals. Furthermore, first-generation animals are gener-
ally mosaic, necessitating additional breeding and geno-
typing. Therefore, this approach does not provide the
most efficient use of animals consistent with the 3R princi-
ples of reduction, refinement, and replacement. CRISPR/
Cas9-mediated gene editing has also been applied in sper-
matogonial stem cells to create knockout rats (Chapman
et al., 2015). Germline genome editing can avoid the pro-
duction of mosaicmutant progeny (Brinster and Avarbock,
1994). However, homologous recombination has yet to be
demonstrated, which limits applications.
Here, we tested whether CRISPR/Cas9 technology can be
applied in rat ESCs both for in vitro studies and for genera-
tion of rats with targeted genomic insertions.e Authors.
ns.org/licenses/by/4.0/).
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RESULTS
Rat Embryonic Stem Cell Derivation and Culture
The culture conditions for rat ESCs were previously
adjusted to reduce spontaneous differentiation by lowering
the concentration of the glycogen synthase kinase-3
(GSK3) inhibitor CHIR99021 (CH) (Chen et al., 2013;
Meek et al., 2013). However, even under these culture con-
ditions, termed t2iL (see Experimental Procedures), rat
ESCs still exhibit unreliable attachment to feeders, incon-
sistent growth rate and viability during routine passaging,
sporadic differentiation, and a tendency to become tetra-
ploid. These issues pose particular concern during the strin-
gent clonal selection and expansion required for gene tar-
geting. Therefore, we assessed several parameters during
derivation of new ESC lines from Dark Agouti rats in t2iL.
Conditions tested were: addition of the PKC inhibitor
Go¨6983 (Rajendran et al., 2013); addition of vitamin C
(250 mM) (Esteban et al., 2010); use of Rho-associated ki-
nase inhibitor Y-27632 (Watanabe et al., 2007); substitu-
tion of DMEM/F12 with lipid-rich advanced DMEM/F12;
reduced oxygen atmosphere. We found that establishment
of cell lines was most reliable using advanced DMEM/F12
in the base N2B27 formulation (Ying et al., 2003) together
with t2iL, and with addition of Y-27632 in 5% O2. We
selected one of the newly derived female ESC lines,
DAC27, for use in subsequent experiments.
We first re-tested the effect of the empirical culture mod-
ifications on colony formation from single DAC27 cells.
Advanced DMEM/F12 and reduced oxygen gave modest
but additive improvements (Figure S1). Addition of Rho-
associated kinase inhibitor Y-27632 (Watanabe et al.,
2007) had a more substantial effect. The combination of
aDMEM/F12, 5% O2 and Y-27632 gave a colony-forming
efficiency of around 80% and moreover made routine
passaging more consistent. We therefore incorporated all
three modifications into the culture system for targeted
genome modification.
Targeted Mutation of Lef1
Expression of the canonical Wnt signaling effector Lef1
has been proposed to underlie the hypersensitivity of ratFigure 1. Generation and Characterization of Lef1 Knockout rESC
(A) Design for CRISPR/Cas9-targeted mutation of Lef1 exon2 and seq
(B) Expression of Lef1 transcript in parental and Lef1 mutant rat ESCs a
replicates.
(C) Expression level of Cdx2 transcript in response to CH at 1 mM or 3
Expression was normalized to Gapdh. ANOVA statistical analysis indica
clone 18 but not in LEF1 mutant clones (clone 24, p = 0.4711; clone
(D) Fluorescent immunostaining of CDX2 and OCT4. Scale bars represe
(E) Colony-forming assay in the presence of 3 mM CH. Undifferentiated,
relative to the total number of colonies counted for each line. Error bar
1264 Stem Cell Reports j Vol. 9 j 1262–1274 j October 10, 2017ESCs to the GSK3 inhibitor CH (Chen et al., 2013). We
therefore chose the Lef1 gene to test the applicability of
CRISPR/Cas9 for targeted gene mutation in rat ESCs.
A gRNA was designed using the CRISPR Design tool
(http://crispr.mit.edu/) to target the second exon of Lef1
(Figure 1A).
For Lef1 targeting, 13 106 rat ESCswere transfected using
Lipofectamine 2000 with 1.2 mg of expression plasmid con-
taining gRNA and Cas9-2A-GFP. Eight hours post transfec-
tion, cells were replated onto new feeders in fresh medium.
Twenty-four hours after replating, GFP-positive cells were
sorted by flow cytometry into 10 cm culture dishes at a den-
sity of 10,000 cells per dish. Fifteen milliliters of medium
was added into each dish, and no medium change was
required thereafter. Five days later, individual colonies
were picked, plated into duplicate 96-wells, and expanded
briefly before genotyping one of the duplicates.
Genomic PCR followed by gel electrophoresis indicated
that 5 of 38 (13%) expanded cultures had an overt deletion
in one or both alleles of Lef1 (Figure S2A).We selected three
clones with distinct gPCR products: cl18, no overt size
change; cl24, one smaller band; cl25, no wild-type band.
We subcloned 24 and 25 and repeated the gPCR screen to
eliminate the possibility of mixed colonies from the pri-
mary plating. We then sequenced the genomic region
spanning Lef1 exon2. Clone 18 had an in-frame deletion
of 3 bp, with no wild-type sequence. Clone 24 had a 2 bp
frameshift mutation in one allele and a deletion of
124 bp in the other allele. Clone 25 had deletions of 173
and 506 bp (Figure 1A).
To assess whether Lef1 expression was indeed disrupted
in these three clones, we designed primers flanking the
gRNA recognition site and performed RT-qPCR analysis
(Figure 1B). Clone 18 yielded a PCR product in similar
amount to parental cells. Consistent with sequencing re-
sults, clone 25 yielded no detectable product. Analysis of
clone 24, on the other hand, indicated a residual level of
transcript. This could be due to incomplete nonsense
mediated mRNA decay of the frameshifted transcript. We
examined LEF1 protein expression by immunocytochem-
istry using a monoclonal antibody that detects an epitope
downstream of the deleted region encoded by exon 2.s
uence of targeted clones.
ssayed by RT-qPCR. Error bars represent the SD from three technical
mM. Error bars represent the SD of three independent experiments.
tes the effect of CH significant (p < 0.0001) in wild-type (WT) and
25, p = 0.1567; ns, not significant; **p < 0.01, ****p < 0.0001).
nt 100 mm.
partially differentiated, and differentiated colonies were calculated
s represent SD from three biological replicates. *p < 0.001 (ANOVA).
Strong stainingwas observed in parental and clone 18 cells,
while clone 24 and clone 25 cells were unstained (Fig-
ure S2B). Collectively, these data indicate that clones 24
and 25 are null mutants lacking LEF1.
We examined the phenotypic consequence of loss of
LEF1. In standard 2iLIF medium containing 3 mM CH
(Ying et al., 2008), expression of Wnt targets related to dif-
ferentiation, such as CDX2, is appreciable in rat ESCs
(Chen et al., 2013; Meek et al., 2013). To investigate
whether inactivating Lef1 could alleviate the hypersensitiv-
ity of rat ESCs to GSK3 inhibition, we first measured the
induction of Cdx2 by RT-qPCR. In parental cells, the
expression of Cdx2 increased more than 6-fold when CH
concentration was raised from 1 mM to 3 mM. Clone 18 cells
showed a similar response to CH, suggesting that loss of a
single amino acid has a minor effect on LEF1 function. In
contrast, the Cdx2 response to CH was reduced in clones
24 and 25 (Figure 1C). Expression of CDX2 protein was
also markedly attenuated in these two Lef1mutant clones,
as shown by immunofluorescence staining (Figure 1D).
To assess whether loss of Lef1 had an impact on the self-
renewal of rat ESCs, we performed colony-forming assays
in the presence of 3 mMCH. Colonies were stained for alka-
line phosphatase and scored for level of differentiation,
categorized as undifferentiated, partially differentiated, or
differentiated. A representative image of each category is
shown in Figure 1E. As previously reported (Chen et al.,
2013), differentiation was overt in around 20% of parental
rat ESCs cultured in 3 mM CH. This was also apparent in
clone 18. In contrast, in clone 24 and clone 25 mutants,
fewer than 5% of colonies contained differentiated cells
(Figure 1E). We also observed that clones 24 and 25 could
be propagated readily in standard 2iLwith no evident detri-
ment compared with t2iL, in contrast to parental or clone
18 cells. These results are consistent with LEF1 mediating
differentiation sensitivity of rat ESCs to GSK3b inhibition.
Generation of a Non-disruptive Sox10 Knockin
Reporter
Based on the proof of principle of genome editing in rat
ESCs, we sought to generate a targeted knockin modifica-
tion via CRISPR/Cas9-facilitated homologous recombina-
tion. We chose the Sox10 gene in order to create a reporter
rat of value to the developmental biology and neuroscience
communities. Sox10 is a member of the Sry-related HMG
box (Sox) family of transcription factors. It is expressed
throughout the developing neural crest (Kelsh, 2006) and
in all oligodendroglial lineage cells (Stolt et al., 2002).
One particular attraction of a Sox10 reporter is as a tool
for visualizing and isolating precursor and mature
oligodendrocytes from postnatal animals. Indeed several
transgenic mouse lines have been created using the Sox10
promoter (Kessaris et al., 2006; Rinholm et al., 2011; Shi-bata et al., 2010; Simon et al., 2012). However, rats inwhich
oligodendrocyte lineage cells are specifically labeled would
be a valuable resource due to the relative ease of surgical
procedures (Iannaccone and Jacob, 2009) and superiority
of demyelinating lesions models in the rat (Woodruff and
Franklin, 1999), combined with their greater suitability
for learning and cognition assays (Iannaccone and Jacob,
2009).
In common with several other Sox gene family members,
Sox10 is haploinsufficient (Britsch et al., 2001; Paratore
et al., 2002). It is therefore essential to avoid disruption of
endogenous SOX10 expression in any knockin reporter.
We designed a construct to insert an internal ribosome
entry site (IRES) coupled to a red fluorescent protein
(HisDsRed) coding sequence into the 30 UTR, leaving the
Sox10 gene structure intact (Figure 2A). dsRed is fused to a
histidinol resistance enzyme, allowing the potential option
for drug selection of Sox10-expressing cells if required. The
insertion site was selected 5 bp downstream of the stop
codon. Fragments of approximately 1.2 kb of genomic
sequence were amplified by genomic PCR to generate
50 and 30 homology arms. Sox10 is not expressed in ESCs;
therefore, positive selection was provided by a PGK-Neo
cassette flanked by Loxp sites.
We designed two gRNAs with recognition sites close to
the designated insertion site in the 30 UTR. We introduced
the gRNAs together with the Sox10-IRES-HisDsRed targeting
vector and Cas9 nickase plasmid into 1 3 106 DAC27 rat
ESCs via lipofection. Use of Cas9 nickase is reported to in-
crease the ratio of homology-directed repair to NHEJ and
reduce off-target genome disruption (Cong et al., 2013;
Mali et al., 2013; Rong et al., 2014). Transfected cells were
replated after 8 hr into 43 10 cm dishes on feeders overlaid
with Matrigel. After 24 hr, G418 (300 mg/mL) selection was
applied. Colonies were picked after 7 days and expanded
without further selection in duplicate for genotyping.
Two of 52 picked colonies, 3B and 6G, yielded a band of
the expected size (1.4 kb) for homologous recombination
detected by genomic PCR using a primer pair flanking the
50 homology arm (Figure 2B). These two clones were vali-
dated further using primers to amplify the reporter region
and the 30 homology arm (Figure S3). To check whether
CRISPR/Cas9 editing had created undesired mutations
close to the gRNA recognition sites, we sequenced these
genomic regions. No mutations were detected in either
clone (Figure 2C).
We assessed the chromosome complement of the two
clones by metaphase analysis. Clone 3B was comprised
of hyperdiploid and tetraploid cells (Figure 2D) and was
discarded. Clone 6G had a proportion of tetraploid cells,
but 13 out of 28 spreads examined (46%) had a euploid
count of 42 chromosomes (Figure 2D). This clone was
therefore chosen to proceed to the next step. Cells wereStem Cell Reports j Vol. 9 j 1262–1274 j October 10, 2017 1265
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Figure 2. Generation of Sox10-dsRed Reporter Transgenic Rat
(A) Design of Sox10 targeting.
(B) Screen for targeting by genomic PCR.
(C) Genomic sequence around gRNA recognition sites in clone 6G cells.
(D) Representative images and chromosome counts of metaphase spreads in Sox10 targeted clones.
(E) Genomic PCR assay for excision of PGK-neoR selection cassette
(F) Chimeras and germline F1 pups following injection of Dark Agouti ESCs 6G-6 and 6G-12 into SD (albino) blastocysts.
(G) Summary of chimeras and test breeding.
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Figure 3. Characterization of Sox10-dsRed Reporter Transgenic Rat
(A) Fluorescent images of E11.5 and E13.5 embryos.
(B) Live sorting of dsRed and dsRed+ cells from E11.5 embryos followed by RT-qPCR for Sox10 transcript. Error bars represent the SD from
three technical replicates.
(C) Immunostaining for dsRed and SOX10 on 100 mm cross-sections of the spinal cord region at E13.5. Scale bars represent 100 mm.
(D) Immunostaining of 100 mm cross-sections of P7 newborn rat cerebellum. The white boxed area is shown in higher magnification in the
right panel. Scale bars represent 100 mm.transfected with a Cre recombinase expression plasmid
and subsequently plated at low density (10,000 cells per
10 cm dish) for sub-cloning. Individual colonies were
picked and split into duplicate wells of a 96-well plate
and cultured with or without G418. Loss of resistance to
the antibiotic indicated excision of the PGK-Neo cassette.
Chromosome counts were again checked by metaphase
analysis. Two of 12 clones, clone 6G-6 and clone 6G-12,
contained at least 50% euploid cells (Figure 2D). Genomic
PCR confirmed the absence of PGKneoR in both clones
(Figure 2E). They were expanded briefly before injection
into blastocysts of the albino SD strain. Coat color chimeras
were obtained in both cases (Figure 2F). Female chimeras
were test mated to SD males and from each clone, two an-
imals proved to be germline competent in the first litter(Figures 2F and 2G). These data demonstrate that rat ESCs
maintained using aN2B27-t2iLY in 5%O2 can maintain
full competence after two rounds of genetic engineering
and clonal selection.
Sox10 Reporter Characterization
Germline offspring from both knockin clones were bred
with SD animals to establish transgenic lines. Heterozygous
outcross matings were employed to characterize reporter
expression.We evaluated the pattern of dsRed fluorescence
at two developmental stages. At embryonic day 11.5
(E11.5), dsRed signal was readily detected in neural crest
cell derivatives and the otic placode (Figure 3A), consistent
with the pattern of SOX10 expression during embryonic
development (Breuskin et al., 2009, 2010). At E13.5,Stem Cell Reports j Vol. 9 j 1262–1274 j October 10, 2017 1267
fluorescence signals were prominent in dorsal root ganglia
(DRG) and trigeminal ganglia, as expected.
We dissociated E11.5 embryos into single cells and sorted
dsRed-positive and -negative populations by flow cytome-
try. Approximately 3.5% live cells were positive for dsRed
fluorescence. The positive and negative populations were
analyzed for Sox10 mRNA by RT-qPCR (Figure 3B). Sox10
transcript was only detected in the dsRed-positive popula-
tion, indicating faithful reporting of endogenous Sox10
transcripts. We carried out double immunofluorescent
staining for SOX10 and dsRed proteins on sections from
E13.5 embryos and P7 newborn rat brain cerebellum. As
shown in Figures 3C and 3D, respectively, SOX10 antibody
stained nuclei in the DRG region of E13.5 embryos and the
cerebellum of P7 neonates. dsRed was detected in the cyto-
plasm of the same subset of cells. Notably, we did not
observe expression of dsRed without co-expression of
SOX10.
Following outcrossing of F1 animals, we set up intercross
matings to acquire homozygotes. Homozygous animals
were obtained from both clones.We euthanized a homozy-
gote at 14 weeks and prepared brain sections. dsRed-posi-
tive cells were evenly distributed across the cortex, corpus
callosum, and sub-cortical regions (Figure S4A). Immuno-
staining for myelin basic protein indicated a normal
pattern of myelin deposition in white and graymatter (Fig-
ures S4B–S4D). Co-expression of dsRed was detected in
Olig2-positive cells and in NG2-positive oligodendrocyte
progenitors (Figures S4E–S4H).
Mice and humans heterozygous for Sox10 loss of func-
tion mutations display overt phenotypes: abnormal
pigmentation and megacolon in mice; Hirschsprung dis-
ease in humans (Britsch et al., 2001; Paratore et al., 2002).
Such haploinsufficiency implies that SOX10 protein
dosage is critical. In contrast, we have observed no abnor-
malities in multiple heterozygous and homozygous ani-
mals. We surmise that Sox10::dsRed knockin rats express
functional SOX10 at physiologically sufficient levels. We
cryopreserved embryos derived from clone 6G-12 and
have deposited live rats with the Rat Resource & Research
Center.
Whole-Cell Patch-Clamp Recording from dsRed-
Positive Oligodendrocyte Lineage Cells
We examined whether this reporter rat can facilitate the
study of oligodendroglial cells. First, we checked whether
a dsRed signal can be detected in living cells in postnatal
rat brain. In freshly prepared coronal brain slices, we iden-
tified dsRed+ cells by fluorescence microscopy in both
cortex (gray matter) and corpus callosum (white matter).
Positive cells displayed morphology of oligodendrocyte
lineage cells (Figure 4A). All stages of oligodendroglia are
expected to be labeled by Sox10:dsRed. To confirm this,1268 Stem Cell Reports j Vol. 9 j 1262–1274 j October 10, 2017fluorescent cells were selected for whole-cell voltage-clamp
recordings. Cells of different lineage stages were identified
based on morphology assessed through live-cell imaging.
Once cells were patched in whole-cell mode, lineage stage
was further evaluated by morphology through additional
lucifer yellow dye labeling. The current response evoked
by a 10 mV pulse (150 ms duration) was used to determine
the decay constant and input resistance, and voltage-cur-
rent membrane properties were used to analyze voltage-
gated sodium and potassium currents. Cartoons and live
images of cortical oligodendrocyte progenitor cells are
shown in Figure 4B. Representative recordings of early
oligodendrocyte progenitors, mature oligodendrocyte pro-
genitors, and fully differentiated oligodendrocyte are
shown in Figures 4C–4E. The electrophysiological proper-
ties are consistent with the morphological assessments of
maturation stage.
Oligodendrocyte lineage cells express glutamate recep-
tors including kainate receptor (Verkhratsky and Stein-
hauser, 2000) and respond to kainate stimulation
(Figure 4F). Therefore, we also measured the kainate
response in dsRed+ cells. More than 80% showed a
response, further indicating that Sox10:dsRed identifies
functional oligodendrocytes in the brain.DISCUSSION
Here, we have documented the application of CRISPR/
Cas9-mediated genome editing in rat ESCs and demon-
strated the utility for generation of in vitro and in vivo
models. Incremental refinements of rat ESC culture condi-
tions conferred more consistent growth and clonogenicity,
facilitating recovery of clones after genetic manipulation.
In addition, we took two further measures to maximize
the probability of germline transmission: first, we used rat
ESCs at low passages; second, we selected diploid clones af-
ter each round of clonal selection. Combined with use of
the CRISPR/Cas9 system, these refinements increase the
practicality of using rat ESCs for gene targeting. Although
the incidence of Sox10 knockinwas only 4%of stable trans-
fectants, the construct used lacked any negative selection
cassette, commonly included to enrich for homologous
recombinants. Ease of vector preparation due to shorter
homology arms is an advantage of using Cas9 compared
with conventional homologous recombination. More
importantly, both of the targeted sub-clones selected for
blastocyst injection gave high-contribution chimerism
and germline transmission.
The creation of Lef1 mutant rat ESCs allowed examina-
tion of the significance of Lef1 downstream of GSK3 inhibi-
tion. This analysis provided further evidence that Lef1
contributes to destabilization of self-renewal via induction
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of lineage specification genes downstream (Chen et al.,
2013; Meek et al., 2013). These results may explain why
the optimal concentration of GSK3 inhibitor CH is only
1 mM compared with 3 mM for mouse ESCs. Interestingly,
human naive pluripotent stem cells also express Lef1 and
show a similar requirement for titrated CH (Takashima
et al., 2014).
Rat ESCs can be exploited as an in vitro differentiation
system, complementary to mouse and human pluripotent
stem cells. Knockin reporters are extremely useful tools in
this context. For example, the Sox10 reporter generated
here could be exploited for monitoring differentiation
into neural crest or oligodendroglia, and for purifying
desired cell populations.
ESC-mediated genome engineering has been transfor-
mative in mouse genetics and now provides similar op-
portunities in the rat, which in several areas of physiology
and neuroscience has considerable advantages over the
mouse as a model species. The Sox10::dsRed rat model
generated here can facilitate study of neuron-oligodendro-
cyte interactions and remyelination. Importantly, the rat
is preferred to the mouse in this context. Notably rats
are used for the cerebellar caudal peduncle (CCP)
ethidium bromide model of myelin regeneration (Gou-
darzvand et al., 2016; Woodruff and Franklin, 1999).
The CCP is one of the few fully myelinated tracts in the
brain and is often affected by demyelinating disease,
such as multiple sclerosis (Preziosa et al., 2014). Rats are
used for this lesion because the CCP is not accessible to
surgery in mice. More generally, neuropharmacology,
cellular distribution of neurotransmitter receptors, and
neurotransmitter receptor structure are more similar be-
tween humans and rats (Hirst et al., 2003). The Sox10 re-
porter rat may also be useful in investigations of white
matter plasticity, taking advantage of the repertoire of
behavioral assays available for rats.
In conclusion, these findings demonstrate that CRISPR/
Cas9 methodology can readily be implemented in rat
ESCs. Genome editing in rat ESCs constitutes a powerful
system for comparative molecular genetic dissection of
in vitro pluripotent stem cell biology. More broadly, theFigure 4. Imaging and and Patch-Clamp Characterization of Sox1
(A) Representation of a cortical Sox10-dsRed rat coronal brain slice. M
oligodendrocyte lineage cells in the rat cortex. Magnification of the
dendrocyte lineage cells in the rat white matter (corpus callosum).
(B–E) Schematic and imaging representation of live dsRed detection
dendrocyte lineage cell during whole-cell patch-clamp recordings (B).
expression levels in dsRed-Sox10+ (C) early oligodendrocyte progen
dendrocytes.
(F and G) Representative response of dsRed-Sox10+ rat oligodendro
responsive and non-responsive DsRed-Sox10+ rat oligodendrocyte lin
from N = 4 separate biological replicates.
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for generating advanced animal models in this important
species for biomedical research.EXPERIMENTAL PROCEDURES
Production of Rat Chimeras
Blastocyst microinjection was carried out as previously described
(Blair et al., 2012) using host blastocysts from the albino
Sprague-Dawley strain. Chimeras were identified by mixed coat
color. All animal studies were approved by the UK Home Office
and carried out in a designated facility.
Cell Culture
Rat ESCs were derived from E4.5 blastocysts from the Dark Agouti
strain andmaintained on g-irradiatedmouse embryo fibroblasts in
aN2B27 medium supplemented with t2iL + Y, consisting of MEK
inhibitor PD0325901 (1 mM), GSK3 inhibitor CHIR99021 (1 mM),
human recombinant leukemia inhibitory factor (10 ng/mL, pre-
pared in house) and Rho-associated kinase inhibitor, Y-27632
(5 mM). Cultures were maintained in a humidified incubator at
37C in 7%CO2 and 5%O2. To prepare aN2B27, we used advanced
DMEM/F12 (Gibco, catalog no. 12491015). Rat ESCs were
routinely passaged by dissociation into single cells with TrypLE Ex-
press every 48 hr and replated at a split ratio between 1:4 and 1:6.
Sufficient culture mediumwas added when seeding the plates that
no change was required until the next passage.
Gene Targeting via CRISPR/Cas9
A newly derived rat ESC line, DAC27, was used at passage 8 for
gene targeting experiments. gRNAs were designed using the
CRISPR Design tool (http://crispr.mit.edu/) to target the desired
region (Table S1). For Lef1 targeting, 1 3 106 rat ESCs maintained
in aN2B27 (t2iL + Y, 5% O2) were transfected using Lipofect-
amine 2000 with 1.2 mg of expression plasmid containing
gRNA, Cas9, and GFP (pSpCas9(BB)-2A-GFP (PX458), a gift
from Feng Zhang; Addgene plasmid no. 48138) (Ran et al.,
2013). Eight hours post transfection, cells were replated onto
new feeders in fresh medium. Twenty-four hours after replating,
GFP-positive cells were sorted by fluorescence-activated cell sort-
ing onto 10 cm culture dishes at a density of 10,000 cells per
dish. Fifteen milliliters of medium was added into each dish
and no medium change was required thereafter. Five days after0-dsRed-Positive Cells in Brain Slices
agnification of red dashed insert shows the live detection of dsRed+
black dashed insert represents the live detection of dsRed+ oligo-
with simultaneous dye-filling with lucifer yellow (LY) of an oligo-
Scale bars represent 10 mm. Characteristic I-V and voltage-gated Nav
itor cells, (D) mature oligodendrocyte progenitors, and (E) oligo-
cyte lineage cells to kainate (30 mM) (F) and the percentage of
eage cells to kainate (G). Total number of cells used for (G), n = 17
seeding, individual colonies were picked, expanded briefly, and
screened using genomic PCR. For generation of Sox10 knockin,
1 3 106 cells were transfected with 1.2 mg of gRNA plasmid,
1.2 mg of Cas9 nickase plasmid, and 1.2 mg of targeting vector.
We used circular plasmids to minimize random integration.
Eight hours post transfection, cells were replated onto
4 3 10 cm culture dishes and G418 selection commenced
24 hr later. Medium was replaced every 24 hr for the first
4 days and every 48 hr thereafter. To ensure robust attachment
of rat ESCs during selection, a thin layer of Matrigel (BD Matri-
gel, 1:240 dilution in MEF medium) was applied to the MEF
feeder layer 24 hr before rat ESC seeding. After 1 week of selec-
tion, individual colonies were picked, expanded briefly, and
screened by genomic PCR. To confirm Lef1 targeted clones, mul-
tiple sets of genotyping primers were used to analyze up to 2.2 kb
around the gRNA recognition site, and genomic PCR products
were sequenced for mutations and deletions (Table S3). To
confirm Sox10 targeted clones, genomic PCR product amplified
using Sox10 set1 (5HA) primers was inserted into TA clones and
sequenced using M13 forward and reverse primers. The region
close to the Sox10 gRNA recognition site was also sequenced us-
ing customized primer to confirm the absence of mutations.
Gene Expression Analysis by Real-Time qPCR
Total RNA was isolated using the RNeasy Kit (QIAGEN) and cDNA
prepared using SuperScriptIII (Invitrogen) and 30RACE adapter
primers. Primers and probes used for real-time PCR are listed in
Table S2.
Chromosome Analysis
Cells were treated for 2.5 hr with colcemide (Gibco, 1:100 dilution)
24 hr after passaging. Metaphase chromosome spreads were pre-
pared and imaged at 633. Chromosomes in discrete spreads were
counted.
Immunofluorescence Cell Staining
Cells were fixed with 4% paraformaldehyde in PBS (pH 7.0) for
30 min at room temperature. Subsequently, cells were washed
twice with PBST (0.1% Triton X-100 [Sigma] in 13 PBS) and
then with blocking solution (4% donkey serum in PBST). Primary
antibody solution was prepared by diluting antibody in blocking
solution at the concentration listed in Table S4. Cells were incu-
bated with the primary antibody at room temperature for 2 hr or
at 4C overnight, followed by three washes with PBS containing
0.1% Tween 20 prior to incubation with the secondary antibodies
at room temperature for 1 hr. After nuclear staining with DAPI
(Invitrogen), stained cells were detected by fluorescence
microscopy.
Fluorescence-Activated Cell Sorting
Fluorescent E11.5 embryos were cut into small pieces before incu-
bating in TrypLE Express enzyme for 15 min at room temperature.
Digested tissue was triturated using a p1000 pipette. Enzyme was
inactivated and diluted with serum containing wash buffer. Larger
debriswas removedwith 100 mmcell strainers before re-suspension
in 1 mL of PBS containing 2% BSA for sorting using a Bio-Rad S3
cell sorter.Immunostaining of Rat Brain
Sox10::dsRed rats at 14 weeks were perfused with 4% paraformalde-
hyde, and coronal sections cut on a vibratome (100mm). Fixed sli-
ces were incubated for 5 hr in 0.5% Triton X-100, 10% goat serum
in PBS at 21C, thenwith primary antibody at 21C overnight, and
then for 5 hr at 21C with secondary antibody. Cryostat sections
were incubated for 1 hr in 0.1% Triton X-100, 10% goat serum in
PBS at 21C, then with primary antibody at 4C overnight, and
then for 1 hr at 21Cwith secondary antibody. Primary antibodies
were: rabbit or mouse RFP (Abcam, 1:100), mouse NG2 (Millipore,
1:100), rabbit Olig2 (Millipore, 1:300), rabbit MBP (Sigma, 1:100).
Secondary antibodies were goat anti-rabbit IgG and anti-mouse
IgG (Life Technologies, 1:1,000). DAPI (Sigma) was used to label
nuclei (10 min, 1 mg/mL).
Electrophysiology
Parasagittal cerebellar slices (225 mm) were prepared from P3-10
Sox10::dsRed rats using a vibrating blade microtome (Leica
VT1200S). After dissection, the brain was placed in a cooled
(1C) oxygenated (95% O2/5% CO2) Krebs solution containing:
126 mM NaCl, 24 nM NaHCO3, 1 mM NaH2PO4, 2.5 mM KCl,
2.5mMCaCl2, 2mMMgCl2, 10mMD-glucose (pH7.4). Kynurenic
acid was included to block glutamate receptors, which might be
activated during the dissection procedure and cause cell damage.
During experiments, slices were superfused with HEPES-buffered
external solution containing: 144 mM NaCl, 2.5 mM KCl,
10 mM HEPES, 1 mM NaH2PO4, 2.5 mM CaCl2, 10 mM glucose,
0.1mMglycine (to co-activateNMDAreceptors), 0.005mMstrych-
nine (to block glycine receptors). pH was set to 7.4 with NaOH and
the solution was permanently bubbled with 100% O2. Recording
electrodes were filled with an internal solution comprising:
130 mM K-gluconate, 4 mM NaCl, 0.5 mM CaCl2, 10 mM HEPES,
10mMBAPTA, 4mMMgATP, 0.5mMNa2GTP, 2mMK-lucifer yel-
low, pH set to 7.3 with KOH; electrode resistance ranged from 5 to
9 MU. Series resistance was left uncompensated and averaged at
30 ± 1.5MU. Electrode junction potential of14mVwas compen-
sated for. A Multiclamp 700B (Molecular Devices) was used for
voltage-clamp data acquisition. Data were sampled at 50 kHz and
filtered at 10 kHz using pClamp10.3 (Molecular Devices).
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